Agenus | AGEN - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 16.62B 840M 2025-12
Agenus USD 34.2M 3.97M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 121K 769K 2025-12
CSL USD 8.33B 4.79B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
Incyte USD 1.51B 140M 2025-12
Intrexon USD 717K 511K 2024-06
J&J USD 24.6B 610M 2025-12
Jiangsu Hengrui CNY 8.44B 1.01B 2025-12
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Merck EUR 5.25B 70M 2025-12
Merck USD 16.4B 880M 2025-12
Northwest Biotherapeutics USD 200K 245K 2025-09
Novartis USD 13.86B 50M 2025-12
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 140.6M 8.7M 2025-12